Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 5 April 1985:
Vol. 228. no. 4695, pp. 73 - 75
DOI: 10.1126/science.3883493
Prev | Table of Contents | Next

Articles

Science, Vol 228, Issue 4695, 73-75
Copyright © 1985 by American Association for the Advancement of Science

articles

Circadian timing of cancer chemotherapy

WJ Hrushesky

Animal studies have indicated that the time of administration of adriamycin and cisplatin, two widely used anticancer drugs, has a profound effect on their toxicity. This effect in cancer chemotherapy was studied in 31 patients with advanced ovarian cancer. Patients received at least eight monthly courses of adriamycin that were followed 12 hours later by cisplatin, with adriamycin randomly administered at either 6 a.m. or 6 p.m. The results show that in the group receiving adriamycin in the evening and cisplatin in the morning (i) twice as many patients required reductions in dosage and delays in treatment, (ii) four times as many treatments had to be delayed, (iii) drug dosages had to be modified downward three times as often, and (iv) even with more dose attenuation and treatment delays, treatment complications were still about two times more common as in the group receiving adriamycin in the morning and cisplatin in the evening. These findings show that the circadian stage at which anticancer drugs are given to patients should be carefully considered.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
{beta}-Catenin Induces {beta}-TrCP-Mediated PER2 Degradation Altering Circadian Clock Gene Expression in Intestinal Mucosa of ApcMin/+ Mice.
X. Yang, P. A. Wood, C. M. Ansell, M. Ohmori, E.-Y. Oh, Y. Xiong, F. G. Berger, M. M. O. Pena, and W. J.M. Hrushesky (2009)
J. Biochem. 145, 289-297
   Abstract »    Full Text »    PDF »
Seasonal and Sex Variation of High-Sensitivity C-Reactive Protein in Healthy Adults: A Longitudinal Study.
D. E. Chiriboga, Y. Ma, W. Li, E. J. Stanek III, J. R. Hebert, P. A. Merriam, E. S. Rawson, and I. S. Ockene (2009)
Clin. Chem. 55, 313-321
   Abstract »    Full Text »    PDF »
Circadian Physiology Is a Toxicity Target of the Anticancer Drug Gemcitabine in Mice.
X.M. Li and F. Levi (2007)
J Biol Rhythms 22, 159-166
   Abstract »    PDF »
The Clock Proteins, Aging, and Tumorigenesis.
R. V. Kondratov and M. P. Antoch (2007)
Cold Spring Harb Symp Quant Biol 72, 477-482
   Abstract »    PDF »
Circadian clock coordinates cancer cell cycle progression, thymidylate synthase, and 5-fluorouracil therapeutic index..
P. A. Wood, J. Du-Quiton, S. You, and W. J.M. Hrushesky (2006)
Mol. Cancer Ther. 5, 2023-2033
   Abstract »    Full Text »    PDF »
Therapeutic Index by Combination of Adriamycin and Docetaxel Depends on Dosing Time in Mice.
M. Tabuchi, H. To, H. Sakaguchi, N. Goto, A. Takeuchi, S. Higuchi, and S. Ohdo (2005)
Cancer Res. 65, 8448-8454
   Abstract »    Full Text »    PDF »
The therapeutic application of melatonin in supportive care and palliative medicine.
F. Mahmoud, N. Sarhill, and M. A. Mazurczak (2005)
American Journal of Hospice and Palliative Medicine 22, 295-309
   Abstract »    PDF »
Persistent twenty-four hour changes in liver and bone marrow despite suprachiasmatic nuclei ablation in mice.
E. Filipski, V. M. King, M.-C. Etienne, X. Li, B. Claustrat, T. G. Granda, G. Milano, M. H. Hastings, and F. Levi (2004)
Am J Physiol Regulatory Integrative Comp Physiol 287, R844-R851
   Abstract »    Full Text »    PDF »
A Recent Illustration of Some Essentials of Circadian Chronotherapy Study Design.
W. Hrushesky, P. Wood, F. Levi, R. von Roemeling, G. Bjarnason, C. Focan, K. Meier, G. Cornelissen, and F. Halberg (2004)
J. Clin. Oncol. 22, 2971-2972
   Full Text »    PDF »
Circadian Timing in Cancer Treatment: The Biological Foundation for an Integrative Approach.
C. G. Lis, J. F. Grutsch, P. Wood, M. You, I. Rich, and W. J M Hrushesky (2003)
Integr Cancer Ther 2, 105-111
   Abstract »    PDF »
The Temporal Organization of Life: the Impact of Multi-frequency Non-linear Biologic Time Structure Upon the Host-Cancer Balance.
W. J. M. Hrushesky (2000)
Jpn. J. Clin. Oncol. 30, 529-533
   Abstract »    Full Text »    PDF »
Chronopharmacology of Antitumor Effect Induced by Interferon-beta in Tumor-Bearing Mice.
H. Takane, S. Ohdo, T. Yamada, E. Yukawa, and S. Higuchi (2000)
J. Pharmacol. Exp. Ther. 294, 746-752
   Abstract »    Full Text »
Marked 24-h Rest/Activity Rhythms Are Associated with Better Quality of Life, Better Response, and Longer Survival in Patients with Metastatic Colorectal Cancer and Good Performance Status.
M.-C. Mormont, J. Waterhouse, P. Bleuzen, S. Giacchetti, A. Jami, A. Bogdan, J. Lellouch, J.-L. Misset, Y. Touitou, and F. Lévi (2000)
Clin. Cancer Res. 6, 3038-3045
   Abstract »    Full Text »
Relationship of atypical melatonin rhythm with two circadian clock outputs in B6D2F1 mice.
X.-M. Li, X.-H. Liu, E. Filipski, G. Metzger, P. Delagrange, J.-P. Jeanniot, and F. Levi (2000)
Am J Physiol Regulatory Integrative Comp Physiol 278, R924-R930
   Abstract »    Full Text »    PDF »
Relationship Between Circadian Rhythm of Vinorelbine Toxicity and Efficacy in P388-Bearing Mice.
E. Filipski, S. Amat, G. Lemaigre, M. Vincenti, F. Breillout, and F. A. Lévi (1999)
J. Pharmacol. Exp. Ther. 289, 231-235
   Abstract »    Full Text »
Chronopharmacology of Granulocyte Colony-Stimulating Factor in Mice.
S. Ohdo, N. Arata, T. Furukubo, E. Yukawa, S. Higuchi, S. Nakano, and N. Ogawa (1998)
J. Pharmacol. Exp. Ther. 285, 242-246
   Abstract »    Full Text »
Replication synchrony-PCR: A sampling-time-independent assay for replication synchrony in human tissues and tumors in situ.
L. De Francesco and R. R. Klevecz (1997)
PNAS 94, 4045-4049
   Abstract »    Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)